Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dishman Carbogen Amcis Ltd. ( (IN:DCAL) ) has provided an announcement.
Dishman Carbogen Amcis Limited has announced that it will host an in-person analyst and investor meeting on 24 December 2025, featuring a plant visit and management interaction at its Bavla, Ahmedabad facility. The company emphasized that discussions during the visit will be confined to information already in the public domain, with no unpublished price-sensitive information to be shared, underscoring its effort to maintain regulatory compliance while enhancing transparency and engagement with the investor community.
More about Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Limited is a listed pharmaceutical and life sciences company, with its equity and debt securities traded on both BSE and the National Stock Exchange of India under the symbol DCAL. The company operates manufacturing facilities, including a plant in Bavla near Ahmedabad, which it showcases to institutional investors and analysts as part of its engagement with the capital markets.
Average Trading Volume: 21,322
Technical Sentiment Signal: Buy
Current Market Cap: 38.09B INR
See more data about DCAL stock on TipRanks’ Stock Analysis page.